Current management of muscle-invasive bladder cancer

Gemma Sancho, Pablo Maroto, Joan Palou

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)


Management of muscle-invasive bladder cancer (MIBC) has changed little in the last twenty years. The gold standard treatment is still cystectomy, but it has a significant negative impact on quality of life. Bladder-preservation strategies can be used in some cases but patient selection for this approach remains unclear. New chemotherapy and biologic agents in combination with surgery or radiotherapy could improve results and these possibilities are currently under investigation.
Original languageEnglish
Pages (from-to)855-861
JournalClinical and Translational Oncology
Issue number12
Publication statusPublished - 1 Dec 2011


  • Chemotherapy
  • Cystectomy
  • Infi ltrating bladder cancer
  • Radiotherapy
  • Transurethral resection of the bladder


Dive into the research topics of 'Current management of muscle-invasive bladder cancer'. Together they form a unique fingerprint.

Cite this